Thomas Brezicka

492 total citations
16 papers, 366 citations indexed

About

Thomas Brezicka is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Thomas Brezicka has authored 16 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Thomas Brezicka's work include Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Thomas Brezicka is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Thomas Brezicka collaborates with scholars based in Sweden and United States. Thomas Brezicka's co-authors include Pam Fredman, Bengt Bergman, Ann E. Mattsson, Björn Lundin, Leif Dotevall, Edward Trybala, D. Lumley, Karin Enarsson, Kristina Nystrôm and Magnus Lindh and has published in prestigious journals such as Water Research, Scientific Reports and European Journal of Immunology.

In The Last Decade

Thomas Brezicka

16 papers receiving 359 citations

Peers

Countries citing papers authored by Thomas Brezicka

Since Specialization

Citations

This map shows the geographic impact of Thomas Brezicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Brezicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Brezicka more than expected).

Fields of papers citing papers by Thomas Brezicka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Brezicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Brezicka. The network helps show where Thomas Brezicka may publish in the future.

Co-authorship network of co-authors of Thomas Brezicka

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Brezicka. A scholar is included among the top collaborators of Thomas Brezicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Brezicka. Thomas Brezicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	From identifying patient safety risks to reporting patient complaints: A grounded theory study on patients' hospital experiences 2024 ·Journal of Clinical Nursing ·(unknown), Thomas Brezicka, Helle Wijk, Kerstin Ulin	1
2	Struggling for access to appropriate healthcare services: A qualitative content analysis of patient complaints 2023 ·Journal of Advanced Nursing ·(unknown), Thomas Brezicka, Helle Wijk, Kerstin Ulin	4
3	The amount of SARS-CoV-2 RNA in wastewater relates to the development of the pandemic and its burden on the health system 2022 ·iScience ·Hao Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Staffan Nilsson, Martin Lagging, Maria Andersson, Leif Dotevall, Thomas Brezicka, Kristina Nystrôm, Heléne Norder	8
4	Development of forecast models for COVID-19 hospital admissions using anonymized and aggregated mobile network data 2022 ·Scientific Reports ·(unknown), (unknown), Selim İckin, (unknown), (unknown), (unknown), Thomas Brezicka, (unknown), (unknown), (unknown), (unknown), Bo Palaszewski, (unknown), Jörgen Gustafsson	1
5	Coexisting service-related factors preceding suicide: a network analysis 2022 ·BMJ Open ·(unknown), Thomas Brezicka, Eric Carlström, Margda Wærn, Lilas Ali	2
6	Time-out in prolonged labour: development of a care model to prevent secondary fear of childbirth 2022 ·BMJ Open Quality ·(unknown), Liselotte Bergqvist, Thomas Brezicka, Ingela Lundgren	4
7	Predicting regional COVID-19 hospital admissions in Sweden using mobility data 2021 ·Scientific Reports ·Philip Gerlee, Julia Karlsson, (unknown), Thomas Brezicka, Armin Sprečo, Toomas Timpka, Anna Jöud, Torbjörn Lundh	4
8	Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19 2020 ·Water Research ·(unknown), (unknown), (unknown), (unknown), (unknown), D. Lumley, (unknown), Leif Dotevall, Ann E. Mattsson, Edward Trybala, Martin Lagging, Magnus Lindh, Magnus Gisslén, Thomas Brezicka, Kristina Nystrôm, Heléne Norder	109
9	CD4⁺CD25^high regulatory T cells reduce T cell transendothelial migration in cancer patients 2006 ·European Journal of Immunology ·Karin Enarsson, Björn Lundin, Erik Johnsson, Thomas Brezicka, Marianne Quiding‐Järbrink	33
10	Expression of epithelial-cell adhesion molecule (Ep-CAM) in small cell lung cancer as defined by monoclonal antibodies 17-1A and BerEP4 2005 ·Acta Oncologica ·Thomas Brezicka	13
11	Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy 2005 ·Cancer Immunology Immunotherapy ·Philip O. Livingston, Chandra Hood, Lee M. Krug, (unknown), Mark G. Kris, Thomas Brezicka, Govind Ragupathi	43
12	Gangliosides as Therapeutic Targets for Cancer 2003 ·BioDrugs ·Pam Fredman, (unknown), Thomas Brezicka	75
13	Supra-Additive Cytotoxic Effects of a Combination of Cytostatic Drugs and Antibody-Induced Complement Activation on Tumor Cells in vitro 2001 ·Tumor Biology ·Thomas Brezicka, Zakaria Einbeigi	4
14	Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues 2000 ·Lung Cancer ·Thomas Brezicka, Bengt Bergman, S. Olling, Pam Fredman	29
15	Functional assessment in vitro of human-complement-dependent antibody-induced cytotoxicity of neoplastic cells 2000 ·Cancer Immunology Immunotherapy ·Thomas Brezicka, (unknown), Bengt Bergman	5
16	Binding specificity of monoclonal antibodies to ganglioside, Fuc-GM1 1986 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Pam Fredman, Thomas Brezicka, Jan Holmgren, Leif Lindholm, Olle Nilsson, Lars Svennerholm	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact